Intrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination treatment
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination treatment
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 3, Issue 10, Pages e415-e415
Publisher
Springer Nature
Online
2012-10-25
DOI
10.1038/cddis.2012.155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- The PIDDosome, DNA-damage-induced apoptosis and beyond
- (2011) S Janssens et al. CELL DEATH AND DIFFERENTIATION
- cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
- (2011) Maria Feoktistova et al. MOLECULAR CELL
- The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
- (2011) Tencho Tenev et al. MOLECULAR CELL
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- Cetuximab-Associated Elongation of the Eyelashes
- (2010) Philip R. Cohen et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Bcl-2 proteins and mitochondria—Specificity in membrane targeting for death
- (2010) Jennefer Lindsay et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells
- (2010) E. Martinelli et al. CLINICAL CANCER RESEARCH
- Focus on histone variant H2AX: To be or not to be
- (2010) Jingsong Yuan et al. FEBS LETTERS
- Synergistic interaction between trastuzumab and EGFR/HER-2 tyrosine kinase inhibitors in HER-2 positive breast cancer cells
- (2010) Norma O’Donovan et al. INVESTIGATIONAL NEW DRUGS
- New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer
- (2010) Robert C. Doebele et al. LUNG CANCER
- EGFR signaling in breast cancer: Bad to the bone
- (2010) John Foley et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer
- (2008) Maura N. Dickler et al. BREAST CANCER RESEARCH AND TREATMENT
- MCF-7 breast carcinoma cells do not express caspase-3
- (2008) Reiner U. Jänicke BREAST CANCER RESEARCH AND TREATMENT
- TNF-α Induces Two Distinct Caspase-8 Activation Pathways
- (2008) Lai Wang et al. CELL
- Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death Pathway
- (2008) Junichi Hitomi et al. CELL
- Synergistic Inhibition of ErbB Signaling by Combined Treatment with Seliciclib and ErbB-Targeting Agents
- (2008) I. N. Fleming et al. CLINICAL CANCER RESEARCH
- Modulation of Cellular Apoptosis with Apoptotic Protease-Activating Factor 1 (Apaf-1) Inhibitors
- (2008) L. Mondragón et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started